Carlsmed
Signal active
Organization
Contact Information
Overview
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbar fusion surgery.
Carlsmed was founded in 2018 and is headquartered in San Diego, California.
About
Industries
Health Care, Manufacturing, Medical Device
Founded
2018
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Carlsmed headquartered in United States, North America, operates in the Health Care, Manufacturing, Medical Device sector. The company focuses on Health Care and has secured $8.1B in funding across 84 round(s). With a team of 11-50 employees, Carlsmed is actively contributing to advancements in Health Care. Their latest funding round, Series C - Carlsmed, raised $52.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
2
Lead Investors
0
Total Funding Amount
$97.0M
Details
5
Carlsmed has raised a total of $97.0M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 10.0M | ||
| 2022 | Early Stage Venture | 30.0M | ||
| 2019 | Seed | |||
| 2024 | Late Stage Venture | 52.5M |
Investors
Carlsmed is funded by 29 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| B Capital | - | FUNDING ROUND - B Capital | 52.5M |
| Jonathan Root | - | FUNDING ROUND - Jonathan Root | 52.5M |
| Carlsmed | - | FUNDING ROUND - Carlsmed | 52.5M |
| U.S. Venture Partners | - | FUNDING ROUND - U.S. Venture Partners | 52.5M |
Recent Activity
There is no recent news or activity for this profile.